Edentulous Alveolar Ridge
Conditions
Keywords
edentulous, narrow alveolar ridges
Brief summary
The objective of this study is to evaluate the survival of narrow dental implants (≤ 3,5 mm) in multiple fixed prostheses in comparison with standard diameter dental implants (≥ 3,75 mm) after 5 years of follow-up. The hypothesis of the study is that narrow dental implants under the evaluated conditions, have the same survival rate and clinical performance than the standard diameter implants.
Interventions
DEVICENarrow dental implants
Insertion of narrow dental implants in multiple fixed prosthesis
Sponsors
Fundación Eduardo Anitua
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Patients of legal age (\>18 years) of both sexes. * Clinical need of multiple fixed alveolar ridge rehabilitations. * Clinical suitability to insert, at least, one narrow dental implant splinted to a standard diameter dental implant. * Signature of the informed consent
Exclusion criteria
* Presence of an active infection * Being under active treatment with, or have received in the las 30 days treatment with radiotherapy, chemotherapy, immunosuppressors, systemic corticosteroids and/or anticoagulants. * Presence of severe haematologic disorders. * Chronic treatment with non steroidal anti-inflammatory drugs (NSAID) or other aniinflammatory drugs. * Previous diagnosis of chronic hepatitis or liver cirrhosis. * Presence of Diabetes mellitus with improper metabolic control (glycosylated haemoglobine higher that 9%). * Patients subjected to dialysis. * Presence of malignant tumours, haemangioma or angioma in the surgical area. * History of ischaemic cardiopathy in the las year. * Pregnancy or plan to getting pregnant during the study. * Metabolic bone disease * Patientd receiving treatment with oral or intravenous biphosphonates. * Any other condition incompatible with the participation in the study,
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survival after 5 years of follow-up | 5 years in comparison with the baseline | Implant survival after 5 years of follow-up |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Marginal Bone Loss | 1, 3 and 5 years in comparison with the baseline | Evolution of the peri-implant bone level along the study follow up |
Countries
Spain
Outcome results
None listed